Richard Blair Gearry (R B Gearry, Richard Gearry, Richard B Gearry)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Topics

Disease Activity

Top Venues

Alimentary pharmacology & therapeutics

JGH open : an open access journal of gastroenterology and hepatology

JMIR research protocols

Therapeutic advances in gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Fatima Hakak, Rajan N Patel, Richard Blair Gearry
Review article: Telecare in gastroenterology-Within the COVID-19 pandemic and beyond. Alimentary pharmacology & therapeutics 59 (10) (2024)
Fatima Hakak, Rajan N Patel, Richard Blair Gearry
Review article: Telecare in gastroenterology-Within the COVID-19 pandemic and beyond. Alimentary pharmacology & therapeutics 59 (10) (2024)
Fatima Hakak, Rajan N Patel, Richard Blair Gearry
Review article: Telecare in gastroenterology-Within the COVID-19 pandemic and beyond. Alimentary pharmacology & therapeutics (2024)
Hwei Min Ng, Jasjot Maggo, Catherine Louisa Wall, Simone Birgit Bayer, Warren Charles McNabb, Jane Adair Mullaney, Meika Foster, Diana L Cabrera, Karl Fraser, Janine M Cooney, Tania Trower, Catrin S Günther, Christopher J Pemberton, Richard Blair Gearry, Nicole Clemence Roy
Effects of Defatted Rice Bran-Fortified Bread on the Gut Microbiota Composition of Healthy Adults With Low Dietary Fiber Intake: Protocol for a Crossover Randomized Controlled Trial. JMIR research protocols 13 (2024)
Fatima Hakak, Rajan N Patel, Richard Blair Gearry
Review article: Telecare in gastroenterology-Within the COVID-19 pandemic and beyond. Alimentary pharmacology & therapeutics 59 (10) (2024)
Alexander Thomas Elford, Rupert W L Leong, Emma P Halmos, Manal Morgan, Kate Kilpatrick, Peter J Lewindon, Richard Blair Gearry, Britt Christensen
IBD barriers across the continents: a continent-specific analysis - Australasia. Therapeutic advances in gastroenterology 16 (2023)
Stephanie Christine Brown, Catherine Louisa Wall, Richard Blair Gearry, Andrew Stewart Day
Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn's Disease: The Patient Perspective. Pediatric gastroenterology, hepatology & nutrition 26 (3) (2023)
Angela J Forbes, Christopher M A Frampton, Andrew Stewart Day, Gilaad G Kaplan, Richard Blair Gearry
The Epidemiology of Inflammatory Bowel Disease in Oceania: A Systematic Review and Meta-Analysis of Incidence and Prevalence. Inflammatory bowel diseases (2023)
Phoebe A Thwaites, Chu Kion Yao, Jasjot Maggo, James John, Adam F Chrimes, Rebecca Elizabeth Burgell, Jane G Muir, Francis C Parker, Daniel So, Kourosh Kalantar-Zadeh, Richard Blair Gearry, Kyle J Berean, Peter R Gibson
Comparison of gastrointestinal landmarks using the gas-sensing capsule and wireless motility capsule. Alimentary pharmacology & therapeutics 56 (9) (2022)
Akhilesh Swaminathan, Thomas C Mules, Richard Blair Gearry
Editorial: measuring disease severity in inflammatory bowel disease-the whole is greater than the sum of its parts. Authors' reply. Alimentary pharmacology & therapeutics 56 (4) (2022)
Akhilesh Swaminathan, Dali Fan, Grace M Borichevsky, Thomas C Mules, Esther Hirschfeld, Chris M Frampton, Andrew Stewart Day, Corey A Siegel, Richard Blair Gearry
The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course. Alimentary pharmacology & therapeutics 56 (4) (2022)
Thomas C Mules, Akhilesh Swaminathan, Richard Blair Gearry
Editorial: brain-gut research needs objective measures of disease activity and mental disorders-authors' reply. Alimentary pharmacology & therapeutics 54 (10) (2021)
Dali Fan, Richard Blair Gearry
Editorial: IBD medications during the COVID-19 pandemic-are they safe to use? Alimentary pharmacology & therapeutics 54 (2) (2021)
Thomas C Mules, Akhilesh Swaminathan, Esther Hirschfeld, Grace Borichevsky, Chris Frampton, Andrew Stewart Day, Richard Blair Gearry
The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease-results from the Stress, Anxiety and Depression with Disease Activity (SADD) Study. Alimentary pharmacology & therapeutics (2021)
Leigh O'Brien, Stephanie Christine Brown, Richard Blair Gearry, Andrew Stewart Day
Letter: low FODMAP diet-directions for future research. Alimentary pharmacology & therapeutics 49 (8) (2020)
Tyara Banerjee, Richard Blair Gearry
Editorial: suicide and IBD-a call to action. Alimentary pharmacology & therapeutics 50 (1) (2020)
Samantha J Benson-Pope, Richard Blair Gearry
Editorial: better outcomes for Crohn's disease-more than just the drugs? Alimentary pharmacology & therapeutics 51 (1) (2020)
Stephanie Christine Brown, Kevin Whelan, Richard Blair Gearry, Andrew Stewart Day
Low FODMAP diet in children and adolescents with functional bowel disorder: A clinical case note review. JGH open : an open access journal of gastroenterology and hepatology 4 (2) (2019)
Richard Blair Gearry, Christopher Frampton, Stephen Inns, David Poppelwell, Marius Rademaker, Ravi Suppiah
VITALITY: impact of adalimumab on health and disability outcomes in patients with Crohn's disease, rheumatoid arthritis, or psoriasis treated in clinical practice in New Zealand. Current medical research and opinion 35 (10) (2019)
Richard Blair Gearry, Charlotte Daker
Editorial: ustekinumab and Crohn's disease-what can we learn from long-term extension studies? Alimentary pharmacology & therapeutics 48 (3) (2019)
Adam J Willington, Richard Blair Gearry
Editorial: thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype-the perils of ageing. Alimentary pharmacology & therapeutics 47 (1) (2017)
Mehul Lamba, V S Tharayil, Richard Blair Gearry
Editorial: does disease extension lead to disease progression in proctitis? Alimentary pharmacology & therapeutics 46 (2) (2017)
M J Lamba, V S Tharayil, Richard Blair Gearry
Editorial: inflammatory bowel disease risk reduction after migration - are early life events important? Alimentary pharmacology & therapeutics 45 (10) (2017)